mots-c and retatrutide represent two completely different pathways working toward the same goal: Metabolic optimization. Retatrutide is changing obesity treatment through its powerful triple agonist mechanism targeting: • GLP-1 • GIP Reta + MOTS-C Only -

EGCG enhancing GLP-1 production and slowing its breakdown for prolonged activity

14 The sulfhydryl group interacts with different biochemical systems, therefore, the active form of glutathione is called GSH

According to these in vitro receptor autoradiography studies, no GLP1Rs were detected in normal human thyroids, whereas C cells of normal rat and mice thyroids expressed GLP1R

The FDA has issued warnings about compounded versions, highlighting serious dosing errors and safety concerns, as the FDA does not oversee the production of these versions

This level of detail is incredibly motivating and can validate that your exercise routine is working even if your total weight hasnt changed dramatically